Cidara Therapeutics Inc (NASDAQ:CDTX)
| 2.43 Delayed Data As of 3:59pm ET |  -0.08 / -3.19%Today’s Change | 1.30 Today|||52-Week Range 4.45 | +21.50% Year-to-Date |
Latest CDTX News | Press Releases
No recent news for Cidara Therapeutics Inc.
Today’s Trading
| Previous close | 2.51 |
| Today’s open | 2.43 |
| Day’s range | 2.30 - 2.56 |
| Volume | 41,247 |
| Average volume (3 months) | 337,991 |
| Market cap | $110.3M |
Data as of 3:59pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | +48.79% |
| Earnings growth (this year) | -9.57% |
| Earnings growth (next 5 years) | +41.25% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 5.34 |
| Price/Book | 2.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LFVNLifeVantage Corp | +0.05 | +0.54% |
| EVOKEvoke Pharma Inc | -0.05 | -1.85% |
| BVXVBiondVax Pharmaceuti... | -0.25 | -4.52% |
| ---- |
Data as of 3:59pm ET, 01/27/2021
Financials
| Next reporting date | March 3, 2021 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $20.9M |
| Annual profit (last year) | -$41.1M |
| Net profit margin | -196.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
